The International Neuromodulation Society defines therapeutic neuromodulation as “the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body.” In appropriate patients, this growing class of therapies, in common use since the 1980s, can help restore function or relieve symptoms that have a neurological basis.
restores function of neurological sites
relieves symptoms that have a neurological basis
HBOT can improve dysexecutive functions, psychiatric symptoms (depression, anxiety and somatisation), pain interference symptoms and fatigue of patients suffering from post-COVID condition.
Restoration of glutathione levels in COVID-19 patients would be a promising approach for the management of the novel coronavirus SARS-CoV-2.
Neuromodulation is a fast-growing discipline that involves using targeted electrical, magnetic, mechanical, or thermal stimulation of the nervous system to change firing neuronal and interneuronal connection features to treat various neurological diseases.
Find Out How Global Neuromodulation in Epilepsy Market Helps The Research and Development Process. Find The Overview and Its Impact in the Future Key Players: Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace.